Inventor · disambiguated record
Matthew Merrill Hayward
Also filed as: HAYWARD MATTHEW M · HAYWARD MATTHEW MERRILL
29 granted patents·22 pending applications·165 citations·filing 2000–2024
96Inventor score
Top patents by PatentIndex Score
51 records- 0195US7928109B2Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2008·Granted Apr 19, 2011·36 cites·4 claims
- 0293US8440822B2Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2012·Granted May 14, 2013·20 cites·38 claims
- 0393US8247411B2Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2011·Granted Aug 21, 2012·22 cites·17 claims
- 0490US10450297B2Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2018·Granted Oct 22, 2019·5 cites·14 claims
- 0590US9617258B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2014·Granted Apr 11, 2017·13 cites·6 claims
- 0690US2025214963A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2024·Application pending·0 cites
- 0789US10144738B2Pyrazolo[1,5-A]PYRAZIN-4-YL derivativesPFIZER·Filed 2017·Granted Dec 4, 2018·7 cites·24 claims
- 0888US9598421B2Imidazopyridazine compoundsPFIZER·Filed 2015·Granted Mar 21, 2017·6 cites·24 claims
- 0987US9642855B2Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2015·Granted May 9, 2017·6 cites·10 claims
- 1086US9695171B23,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitorsPFIZER·Filed 2014·Granted Jul 4, 2017·10 cites·7 claims
- 1186US9120788B2Azabenzimidazole compoundsPFIZER·Filed 2014·Granted Sep 1, 2015·8 cites·33 claims
- 1285US2024109862A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2023·Application pending·0 cites
- 1384US2025134869A1Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-midesPFIZER·Filed 2024·Application pending·0 cites
- 1483US10738063B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2019·Granted Aug 11, 2020·3 cites·16 claims
- 1583US9815832B2Azabenzimidazole compoundsPFIZER·Filed 2015·Granted Nov 14, 2017·4 cites·26 claims
- 1683US9156845B24-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2013·Granted Oct 13, 2015·6 cites·24 claims
- 1780US12129256B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2022·Granted Oct 29, 2024·0 cites·4 claims
- 1879US2022251066A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2021·Application pending·0 cites
- 1975US10323042B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2017·Granted Jun 18, 2019·1 cites·18 claims
- 2074US10077269B2Imidazopyridazine compoundsPFIZER·Filed 2017·Granted Sep 18, 2018·1 cites·7 claims
- 2174US8183238B2Bicyclic and tricyclic compounds as KAT II inhibitorsCLAFFEY MICHELLE M·Filed 2010·Granted May 22, 2012·5 cites·13 claims
- 2273US12077533B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2021·Granted Sep 3, 2024·0 cites·2 claims
- 2372US2020002310A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2019·Application pending·0 cites
- 2470US11472809B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2020·Granted Oct 18, 2022·0 cites·4 claims
- 2570US10822341B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2018·Granted Nov 3, 2020·0 cites·23 claims
- 2669US10669279B2Imidazopyridazine compoundsPFIZER·Filed 2019·Granted Jun 2, 2020·0 cites·22 claims
- 2769US6974817B2Sulfonic acid derivativesPFIZER·Filed 2002·Granted Dec 13, 2005·3 cites·53 claims
- 2868US6562792B1Hygromycin derivativesPFIZER·Filed 2000·Granted May 13, 2003·4 cites·20 claims
- 2967US2015080368A1Sulfonyl amide derivatives for the treatment of abnormal cell growthVERASTEM INC·Filed 2014·Application pending·0 cites
- 3065US11111242B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2017·Granted Sep 7, 2021·0 cites·12 claims
- 3165US2017327485A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2017·Application pending·0 cites
- 3263US6867230B2Hygromycin A derivativesPFIZER·Filed 2001·Granted Mar 15, 2005·2 cites·8 claims
- 3363US2014100368A1Sulfonyl amide derivatives for the treatment of abnormal cell growthLUZZIO MICHAEL JOSEPH·Filed 2013·Application pending·0 cites
- 3463US2017001981A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2016·Application pending·0 cites
- 3562US2016130250A1Sulfonyl amide derivatives for the treatment of abnormal cell growthPFIZER·Filed 2016·Application pending·0 cites
- 3660US7098212B2Piperazine derivativesBLUMBERG LAURA C·Filed 2002·Granted Aug 29, 2006·3 cites·20 claims
- 3760US2018346475A1Imidazopyridazine CompoundsPFIZER·Filed 2018·Application pending·0 cites
- 3851US2005250790A1Novel sulfonic acid derivativesPFIZER·Filed 2005·Application pending·0 cites
- 3949US2010035873A1Diaryl Compounds and Uses ThereofPFIZER·Filed 2009·Application pending·0 cites
- 4048US10703756B2Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereofPFIZER·Filed 2016·Granted Jul 7, 2020·0 cites·5 claims
- 4146US2003055053A14-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivativesFiled 2002·Application pending·0 cites
- 4246US2004127465A1Novel phosphorus-containing derivativesPFIZER·Filed 2003·Application pending·0 cites
- 4344US11254668B2Pyrazolo[1,5-A]pyrazin-4-yl and related derivativesPFIZER·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 4444US2004092529A1Methods of using piperazine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 4544US2004063759A1Novel piperidine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 4644US2004063688A1Novel piperidine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 4744US2004116441A1Methods of using sulfonic acid derivativesPFIZER·Filed 2003·Application pending·0 cites
- 4843US2005119275A1Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acidPFIZER·Filed 2004·Application pending·0 cites
- 4943US2002016297A14-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivativesFiled 2000·Application pending·0 cites
- 5041US2019270778A1Cyclic Peptides As C5a Receptor AntagonistsPFIZER·Filed 2017·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Matthew Merrill Hayward files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →